Latest news
CRISPR Therapeutics (NASDAQ:CRSP) Rating Increased to Hold at Wall Street Zen - MarketBeatMarketBeat · Sat, 08 Aug 2026 05:48:57 GMTHC Wainwright Has Positive Forecast for CRSP FY2026 Earnings - MarketBeatMarketBeat · Fri, 07 Aug 2026 11:30:16 GMTCalifornia State Teachers Retirement System Increases Stock Position in CRISPR Therapeutics AG $CRSP - MarketBeatMarketBeat · Fri, 07 Aug 2026 08:22:56 GMTBrave Asset Management Inc. Cuts Stake in CRISPR Therapeutics AG $CRSP - MarketBeatMarketBeat · Fri, 07 Aug 2026 08:20:29 GMTDimensional Fund Advisors LP Sells 412,889 Shares of CRISPR Therapeutics AG $CRSP - MarketBeatMarketBeat · Fri, 07 Aug 2026 08:20:28 GMTEquities Analysts Offer Predictions for CRSP Q3 Earnings - MarketBeatMarketBeat · Thu, 06 Aug 2026 14:36:31 GMTBrokers Offer Predictions for CRSP FY2028 Earnings - MarketBeatMarketBeat · Wed, 05 Aug 2026 11:08:43 GMTCRISPR Therapeutics (NASDAQ:CRSP) Announces Quarterly Earnings Results, Beats Estimates By $0.26 EPS - MarketBeatMarketBeat · Mon, 03 Aug 2026 21:38:48 GMT